НовостиBenzingaRBC Capital Initiates Coverage On Eupraxia Pharmaceuticals with Outperform Rating, Announces Price Target of $14 RBC Capital Initiates Coverage On Eupraxia Pharmaceuticals with Outperform Rating, Announces Price Target of $14 Benzinga 2026.11.09 13:41 (GMT+0) Открыть на Benzinga Другие новости